Risk Intelligence
Not Available
Not Scored
How strong and defensively sound is the company?
This reading is not available for this company yet.
DOC · NYSE
Sector unavailable · Industry unavailable
$20.30
-0.34%
Close on Sep 11, 2026
Updated 6/30/2026
Long-term research evidence only. No price targets, no trading signals, no recommendations.
Investment Report Card
Sector unavailable · Data confidence limited
No Suggested Investment Score today
Risk Intelligence is unavailable
Not Available
Not Scored
How strong and defensively sound is the company?
This reading is not available for this company yet.
Not Available
Not Scored
Does the business have the characteristics needed to create value over many years?
This reading is not available for this company yet.
Not Available
Not Scored
Is the underlying business getting stronger or weaker?
This reading is not available for this company yet.
Not Available
Positive disclosed activity
What are important owners actually doing?
This reading is not available for this company yet.
65 / 100
Attractive
Is today's price reasonable?
Around the middle of the covered universe — and valuation is researched separately from the Suggested Investment Score.
39 / 100
Limited Capital Returns
How effectively does the company reward shareholders?
Weaker than most covered companies on this measure — and capital returns are researched separately from the Suggested Investment Score.
No weakening evidence is recorded in today's readings.
Long-Term Potential is not available for this company, so no long-term reading is shown.
No disclosed ownership reading is available at the required confidence, so ownership is left blank rather than estimated.
HEALTHPEAK PROPERTIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
HEALTHPEAK PROPERTIES INC reads 39 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting a dividend paid for 13 consecutive years and a share count rising about 4.8% a year. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.
No meaningful recorded changes in the stored history.
Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.
Compare DOC with other companiesAppears in
Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.
60-Second Brief
Too few stored readings exist for this company to summarise honestly.
Composite discovery model
Suggested Investment Score
Risk Intelligence is unavailable. A composite score is only published when every required input is available for this company. Nothing is estimated to fill a gap, and exclusion from the ranking is not a sell instruction.
COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Ranking updated September 12, 2026
Researched separately
Valuation Intelligence 65 · Attractive
Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.
Researched separately
Capital Returns Intelligence 39 · Limited Capital Returns
Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.
This company does not currently hold a stored Suggested Investment Score, so no contribution breakdown can be shown.
Stored snapshots only
Research-score history available since September 2026.
Stored research history does not yet cover a full 30 days comparison for this company.
A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.
Plain-English definitions, with the formula and the limitations of each measure.
Fifth research lens · outside the score
Valuation Intelligence
Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.
Attractive
73
Very Attractive
Is this company expensive or inexpensive compared with its own history?
68
Attractive
How expensive is this stock compared with similar companies?
78
Very Attractive
How much financial output does an investor receive relative to the price paid?
32
Expensive
Does the company's growth help justify the valuation investors are paying?
HEALTHPEAK PROPERTIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.
Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026
Stored readings only. The dashed line is this company's own median for the selected measure.
Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.
Current Price / Book 1.8x · own median 2.2x · peer median 2.0x
Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.
Sixth research lens · outside the score
Capital Returns Intelligence
Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.
Limited Capital Returns
33
Limited Capital Returns
Dividend reliability
42
Moderate Capital Returns
Do buybacks actually reduce shares?
The company spends on share repurchases, but much of that activity offsets share issuance rather than materially reducing the share count.
15
Limited Capital Returns
Is your ownership share protected?
62
Favorable Capital Returns
Can the cash flow support it?
44
Moderate Capital Returns
Cash returned versus company value
HEALTHPEAK PROPERTIES INC reads 39 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting a dividend paid for 13 consecutive years and a share count rising about 4.8% a year.
This company spent cash repurchasing stock, but the share count did not fall meaningfully because it also issued shares. Repurchase spending alone did not increase existing shareholders' ownership.
How returned cash was used
Dividends $845.99M · net repurchases $99.96M · total returned $945.94M
Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026
Stored readings only. History builds forward from activation rather than being reconstructed.
Only one stored reading exists for this measure so far, so there is nothing to chart yet.
A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.
Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.
Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Suggested Investment Score.
Stored daily snapshots only
| Today | Not ranked | No stored score |
|---|---|---|
| 30 days ago | Not ranked | No stored score |
| 90 days ago | Not ranked | No stored score |
| First suggested | Not yet suggested | |
| Highest rank | Not ranked | |
In the company’s own words
Healthpeak Properties, Inc. is a Standard & Poor’s ("S&P") 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States ("U.S."). Our company was originally founded in 1985. We are organized as an umbrella partnership REIT ("UPREIT"). We hold substantially all of our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S.
We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and senior housing real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the senior housing segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) loans receivable, (ii) a preferred equity investment, and (iii) three other properties . These non-reportable segments have been p resented on a combined basis herein.
On March 1, 2024 (the "Closing Date"), we completed our merger with Physicians Realty Trust (the "Merger"). Subsequent to the Closing Date, the "Combined Company" means Healthpeak and its subsidiaries. As a result of the Merger, we acquired 299 outpatient medical buildings. See Note 3 to the Consolidated Financial Statements for additional information.
In December 2025, we confidentially submitted a draft registration statement on Form S-11 to the SEC relating to the proposed initial public offering (the "Offering" or "Janus Living Offering") of shares of common stock of a newly formed company, Janus Living, Inc. ("Janus Living"), which will be dedicated to senior housing and which intends to elect and qualify to be taxed as a REIT. We will contribute our 34-community, 10,422-unit senior housing portfolio to Janus Living in exchange for a majority ownership interest in Janus Living. Immediately following the Janus Living Offering, we will serve as its external manager and we intend to retain a substantial majority interest in Janus Living, with new public shareholders owning the remaining interest. Based on the anticipated ownership share and terms of the management agreement, we expect to continue to consolidate Janus Living subsequent to the Offering. We expect to complete the Offering in the first half of 2026, subject to market conditions, receipt of regulatory approvals, completion of related financings, completion of the SEC’s review, and other customary conditions.
Quoted from the business section of this company’s 10-K filed February 3, 2026. Read the filing
Four distinct intelligence areas
—
Insufficient Data
No prior period to compare
Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.
—
Insufficient Data
No prior period to compare
Durable business economics and reinvestment characteristics. Independent external validation is pending.
—
Insufficient Data
No prior period to compare
Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.
75
Upper range
0 vs Jun 30, 2026
Only 4 tracked managers disclosed a position — treat as limited coverage.
As of Sep 11, 2026
Company intelligence
Each area is measured and reported separately. No combined score exists.
DOC intelligence history from 2023-09-30 to 2026-09-11. Elite Investor Activity 75 on 2026-09-11, unchanged 0 from 75 on 2026-06-30. Each area is reported separately and is never combined into a single score.
Elite Investor Activity 75 as of Sep 11, 2026 (0 vs prior period) · Supplemental
Share price
Closing prices adjusted for splits and dividends, through Sep 11, 2026. Past prices do not indicate future results.
Last stored close $20.30 · +19.6% over the selected range · 52 sessions shown
Balanced evidence
Risk and uncertainty
Public filings · descriptive only
Reporting holders
1
New holders
1
Increasing
0
Reducing
0
Exiting
0
Coverage
Excellent
Positive disclosed activity · Report period 2016-12-31 · Public 12/22/2023
| Manager | Change | Portfolio weight | Rank | Disclosed |
|---|
Insufficient high-confidence manager coverage.
Objective stored changes
Elite Investor Consensus strengthened
Disclosed agreement among tracked managers moved from 67 to 75 for the reporting period ending 2026-06-30.
Elite Investor Consensus strengthened
Disclosed agreement among tracked managers moved from 50 to 67 for the reporting period ending 2026-03-31.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 63 to 50 for the reporting period ending 2025-12-31.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 83 to 63 for the reporting period ending 2025-09-30.
Elite Investor Consensus strengthened
Disclosed agreement among tracked managers moved from 67 to 83 for the reporting period ending 2025-06-30.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 83 to 67 for the reporting period ending 2025-03-31.
Elite Investor Consensus weakened
Disclosed agreement among tracked managers moved from 100 to 83 for the reporting period ending 2024-12-31.
Tracked managers initiated positions
3 tracked managers first disclosed a position for the reporting period ending 2024-09-30.
No high-confidence public ownership events are available.
General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.